A detailed history of Morgan Stanley transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,132,447 shares of AVNS stock, worth $20.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,132,447
Previous 359,098 215.36%
Holding current value
$20.2 Million
Previous $7.15 Million 280.43%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$19.21 - $24.69 $14.9 Million - $19.1 Million
773,349 Added 215.36%
1,132,447 $27.2 Million
Q2 2024

Oct 17, 2024

SELL
$17.85 - $20.42 $971,557 - $1.11 Million
-54,429 Reduced 13.16%
359,098 $7.15 Million
Q2 2024

Aug 14, 2024

SELL
$17.85 - $20.42 $971,557 - $1.11 Million
-54,429 Reduced 13.16%
359,098 $7.15 Million
Q1 2024

Oct 17, 2024

BUY
$17.97 - $22.68 $978,089 - $1.23 Million
54,429 Added 15.16%
413,527 $8.23 Million
Q1 2024

Aug 16, 2024

SELL
$17.97 - $22.68 $935,176 - $1.18 Million
-52,041 Reduced 11.18%
413,527 $8.23 Million
Q1 2024

May 15, 2024

SELL
$17.97 - $22.68 $935,176 - $1.18 Million
-52,041 Reduced 11.18%
413,527 $8.23 Million
Q4 2023

Aug 16, 2024

BUY
$17.64 - $22.99 $1.88 Million - $2.45 Million
106,470 Added 29.65%
465,568 $10.4 Million
Q4 2023

Feb 13, 2024

BUY
$17.64 - $22.99 $393,354 - $512,654
22,299 Added 5.03%
465,568 $10.4 Million
Q3 2023

Nov 15, 2023

BUY
$19.93 - $26.31 $336,199 - $443,823
16,869 Added 3.96%
443,269 $8.96 Million
Q2 2023

Aug 14, 2023

SELL
$22.53 - $30.98 $3.61 Million - $4.96 Million
-160,028 Reduced 27.29%
426,400 $10.9 Million
Q1 2023

May 15, 2023

BUY
$26.92 - $31.75 $2.47 Million - $2.91 Million
91,615 Added 18.52%
586,428 $17.4 Million
Q4 2022

Feb 14, 2023

BUY
$19.88 - $27.37 $1,948 - $2,682
98 Added 0.02%
494,813 $13.4 Million
Q3 2022

Nov 14, 2022

SELL
$21.56 - $29.59 $1.22 Million - $1.67 Million
-56,369 Reduced 10.23%
494,715 $10.8 Million
Q2 2022

Oct 27, 2022

BUY
$24.87 - $34.68 $2.31 Million - $3.22 Million
92,718 Added 20.23%
551,084 $15.1 Million
Q2 2022

Aug 15, 2022

BUY
$24.87 - $34.68 $2.31 Million - $3.22 Million
92,718 Added 20.23%
551,084 $15.1 Million
Q1 2022

Oct 27, 2022

SELL
$28.87 - $35.77 $2.68 Million - $3.32 Million
-92,718 Reduced 16.82%
458,366 $15.4 Million
Q1 2022

May 13, 2022

BUY
$28.87 - $35.77 $6.82 Million - $8.44 Million
236,066 Added 106.19%
458,366 $15.4 Million
Q4 2021

Feb 14, 2022

SELL
$29.25 - $36.02 $274,511 - $338,047
-9,385 Reduced 4.05%
222,300 $7.71 Million
Q3 2021

Nov 15, 2021

BUY
$31.2 - $38.5 $7.23 Million - $8.92 Million
231,685 New
231,685 $7.23 Million

Others Institutions Holding AVNS

About AVANOS MEDICAL, INC.


  • Ticker AVNS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 46,487,000
  • Market Cap $831M
  • Description
  • Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...
More about AVNS
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.